These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10874052)

  • 81. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
    Zhang X; Dong Y; Zeng X; Li Y; Tang F
    Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital.
    Draibe J; Poveda R; Fulladosa X; Vidaller A; Zulberti C; Gomà M; Pujol R; Ripoll È; Torras J; Grinyó JM
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i132-7. PubMed ID: 25805744
    [TBL] [Abstract][Full Text] [Related]  

  • 83. ANCA Glomerulonephritis and Vasculitis.
    Jennette JC; Nachman PH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Successful treatment of severe ANCA-associated RPGN with high-dose IVIg therapy].
    Gomada M; Akamatsu A
    Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):79-83. PubMed ID: 15058108
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement.
    Blum M; Andrassy K; Adler D; Hartmann M; Völcker HE
    Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):599-602. PubMed ID: 9342611
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis.
    Han WK; Choi HK; Roth RM; McCluskey RT; Niles JL
    Kidney Int; 2003 Mar; 63(3):1079-85. PubMed ID: 12631091
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Keogh KA; Wylam ME; Stone JH; Specks U
    Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis.
    Hassan TM; Hassan AS; Igoe A; Logan M; Gunaratnam C; McElvaney NG; O'Neill SJ
    BMC Immunol; 2014 May; 15():20. PubMed ID: 24884372
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.
    Booth A; Harper L; Hammad T; Bacon P; Griffith M; Levy J; Savage C; Pusey C; Jayne D
    J Am Soc Nephrol; 2004 Mar; 15(3):717-21. PubMed ID: 14978174
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Remittent non-destructive polysynovitis in P-ANCA-positive vasculitis patients with anti-CCP antibodies.
    Pagnoux C; Seror R; Bérezné A; Rouabhia S; Goulvestre C; Guillevin L
    Joint Bone Spine; 2010 Dec; 77(6):604-7. PubMed ID: 20483651
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Allen A; Pusey C; Gaskin G
    J Am Soc Nephrol; 1998 Jul; 9(7):1258-63. PubMed ID: 9644636
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature.
    Quéméneur T; Mouthon L; Cacoub P; Meyer O; Michon-Pasturel U; Vanhille P; Hatron PY; Guillevin L; Hachulla E
    Medicine (Baltimore); 2013 Jan; 92(1):1-9. PubMed ID: 23263715
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Intravital microscopy in the study of ANCA-associated systemic vasculitis.
    Little MA; Pusey CD; Nourshargh S
    Clin Nephrol; 2005 Dec; 64(6):465-70. PubMed ID: 16370161
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [High dosage intravenous immunoglobulin (IVIG) therapy in therapy-refractory ANCA-negative, necrotizing vasculitis].
    Altmeyer P; Seifarth D; Bacharach-Buhles M
    Hautarzt; 1999 Dec; 50(12):853-8. PubMed ID: 10663019
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.
    Merkel PA; Cuthbertson DD; Hellmich B; Hoffman GS; Jayne DR; Kallenberg CG; Krischer JP; Luqmani R; Mahr AD; Matteson EL; Specks U; Stone JH;
    Ann Rheum Dis; 2009 Jan; 68(1):103-6. PubMed ID: 18664546
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Marked improvement of Churg-Strauss vasculitis with intravenous gammaglobulins.
    Levy Y; George J; Fabbrizzi F; Rotman P; Paz Y; Shoenfeld Y
    South Med J; 1999 Apr; 92(4):412-4. PubMed ID: 10219362
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis.
    Uozumi R; Iguchi R; Masuda S; Nishibata Y; Nakazawa D; Tomaru U; Ishizu A
    Mod Rheumatol; 2020 May; 30(3):544-550. PubMed ID: 30932727
    [No Abstract]   [Full Text] [Related]  

  • 98. Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.
    Sami N; Bhol KC; Ahmed AR
    Clin Exp Immunol; 2002 Sep; 129(3):533-40. PubMed ID: 12197896
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combination rituximab and intravenous immunoglobulin for treatment of refractory vasculitic neuropathy: a case series.
    Lima K; Tavee J; Dua A
    Rheumatology (Oxford); 2021 Oct; 60(10):4884-4887. PubMed ID: 33502498
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.
    Thorpe CT; Devellis RF; Lewis MA; Blalock SJ; Hogan SL; Devellis BM
    Arthritis Rheum; 2007 Oct; 57(7):1296-302. PubMed ID: 17907222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.